超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

健能隆Generon
生物醫藥是現代制藥產業的重要支柱，健能隆致力于運用現代生物技術，按照國際標準研發創新型生物醫藥產品，在研產品主要針對尚未解決的醫療難題，如腫瘤、炎癥和自身免疫性疾病等。 我們立足于在中國進行新藥研發， 并將產品推入國際市場。我們的理想是“以創新為本，做更好的藥”。我們的社會責任是“讓更多的中國病人，用得上高品質的生物藥”。
自創建以來，公司建立了高效哺乳動物細胞的蛋白表達技術及完整的新藥研發技術平臺，已開發出多個處在不同研發階段的創新生物藥，并擁有這些產品生產的關鍵技術及其國內、國際專利。健能隆的獨特競爭優勢，吸引了國內外具有多年國際新藥研發經驗的專業技術人才加盟，我們將不懈努力地將健能隆打造成一個在全球現代生物醫藥領域中具有重要影響力的企業。
在此，我真誠地感謝所有支持和幫助健能隆的各級領導、朋友和合作伙伴。我們承諾，作為一個正在崛起的生物醫藥企業，健能隆人堅信自己的理念和追求，將用智慧與汗水，生產出更多造福人類的創新生物藥物，實現經濟效益和社會效益的最大化。

Generon (Shanghai) Corporation (GC) is a biotech company, located at Zhang-Jiang Hi-Tech Park, Shanghai, China. Our company is focused on developing protein therapeutics to treat human diseases with unmet medical needs. We conduct research and development according to the highest standards and to meet regulatory requirements of SFDA and FDA/EMA. We aim to bring our drugs to both domestic and international markets with our partners, especially to bring patients with more affordable and high-quality bio-medicines. Generon is a young and energetic biotech company consisting of highly motivated entrepreneurs and scientists with expertise covering the new drug discovery and development process and with a passion to 'Innovate for Life'. We have established a number of cutting-edge technology platforms including recombinant protein engineering, high expression of proteins in mammalian cells, and scale-up manufacturing. We have established a pipeline with strong IP protection and with balanced risks for development consisting of bio-better, and bio-innovative products.I would like to sincerely thank our friends and partners for your help and support! And thank our team members for your hard working, dedication and great contributions! Working together, we will bring new medicines to patients.